Paul Mellor
Prince Albert, SK, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
CLIC3 is upregulated across all subtypes of breast cancer and plays a key role in cell migration, invasion and growth in soft agar.
Journal: Breast cancer research : BCR
Published: November 12, 2025
Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: January 06, 2025
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel.
Journal: Scientific reports
Published: May 03, 2022
Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
Journal: PloS one
Published: June 14, 2021
Insight into the PTEN - p85α interaction and lipid binding properties of the p85α BH domain.
Journal: Oncotarget
Published: August 09, 2018
Patient-derived mutations within the N-terminal domains of p85α impact PTEN or Rab5 binding and regulation.
Journal: Scientific reports
Published: January 18, 2018
Molecular characterization of breast cancer cell lines through multiple omic approaches.
Journal: Breast cancer research : BCR
Published: January 13, 2017
The role of PTEN - HCV core interaction in hepatitis C virus replication.
Journal: Scientific reports
Published: September 16, 2016
Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
Journal: Breast cancer research : BCR
Published: August 13, 2015
CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion, and angiogenesis.
Journal: Molecular and cellular biology
Published: October 16, 2013
Last Updated: 09/26/2026